<--- Back to Details
First PageDocument Content
Givinostat / Myelofibrosis / European Medicines Agency / Orphan drug / Myeloproliferative disease / Hydroxycarbamide / Blood / Janus kinase 2 / Medicine / Hematopathology / Polycythemia
Date: 2013-07-21 06:00:38
Givinostat
Myelofibrosis
European Medicines Agency
Orphan drug
Myeloproliferative disease
Hydroxycarbamide
Blood
Janus kinase 2
Medicine
Hematopathology
Polycythemia

Add to Reading List

Source URL: www.ema.europa.eu

Download Document from Source Website

File Size: 110,72 KB

Share Document on Facebook

Similar Documents

BLOOD TEST FORM Patient Name: ___________________________________________ Please deliver a copy of the following laboratory results, performed within the last 12 months:  

DocID: 1xVRc - View Document

Tyrannosaurus / Montana / Environment of the United States / Paleontology in Montana / Paleontology in the United States / Mary Higby Schweitzer / Tyrannosaurids / Jack Horner / Specimens of Tyrannosaurus / Ica stones / Schweitzer / Carl Wieland

ch 16 fresh dino blood.fm

DocID: 1xViN - View Document

Blood / Anatomy / Hematology / Histology / Hematocrit / Serum albumin / Albumin / Serum / Blood plasma / Microfluidics

PROTEIN QUANTITATION FROM WHOLE BLOOD ON POLYESTER-TONER LASER-PRINTED MICROFLUIDIC DISCS WITH CELL PHONE IMAGE ANALYSIS Brandon L. Thompson1, Yiwen Ouyang1,5, Jingyi Li1, Shannon T. Krauss1, Nishant Shukla2, Bryan G. Ke

DocID: 1xVdT - View Document

DOI:http://dx.doi.orgAPJCPBlood Groups and Risk of Cancer: a Systematic Review and Meta-Analysis RESEARCH ARTICLE ABO Blood Groups and Risk of Cancer: a Systematic Review and Meta-analysis

DocID: 1xVc0 - View Document

PDF Document

DocID: 1x6hI - View Document